| Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders K Katisko, A Cajanus, O Jääskeläinen, A Kontkanen, P Hartikainen, ... Journal of neurology 267, 162-167, 2020 | 95 | 2020 |
| GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance K Katisko, A Cajanus, N Huber, O Jääskeläinen, T Kokkola, V Kärkkäinen, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (12), 1305-1312, 2021 | 38 | 2021 |
| mNos2 Deletion and Human NOS2 Replacement in Alzheimer Disease Models CA Colton, JG Wilson, A Everhart, DM Wilcock, J Puoliväli, T Heikkinen, ... Journal of Neuropathology & Experimental Neurology 73 (8), 752-769, 2014 | 34 | 2014 |
| Circulating neurofilament is linked with morbid obesity, renal function, and brain density E Rebelos, E Rissanen, M Bucci, O Jääskeläinen, MJ Honka, ... Scientific reports 12 (1), 7841, 2022 | 29 | 2022 |
| Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis A Cajanus, K Katisko, A Kontkanen, O Jääskeläinen, P Hartikainen, ... Annals of clinical and translational neurology 7 (6), 903-910, 2020 | 20 | 2020 |
| Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis M Niiranen, A Kontkanen, O Jääskeläinen, HM Tertsunen, T Selander, ... Multiple Sclerosis and Related Disorders 56, 103280, 2021 | 17 | 2021 |
| Metabolic profiles help discriminate mild cognitive impairment from dementia stage in Alzheimer’s disease O Jääskeläinen, A Hall, M Tiainen, M Van Gils, J Lötjönen, AJ Kangas, ... Journal of Alzheimer's Disease 74 (1), 277-286, 2020 | 16 | 2020 |
| Low serum high-density lipoprotein cholesterol levels associate with the C9orf72 repeat expansion in frontotemporal lobar degeneration patients O Jääskeläinen, E Solje, A Hall, K Katisko, V Korhonen, M Tiainen, ... Journal of Alzheimer's Disease 72 (1), 127-137, 2019 | 15 | 2019 |
| Cerebrospinal fluid and MRI biomarkers in neurodegenerative diseases: A retrospective memory clinic-based study A Kaipainen, O Jääskeläinen, Y Liu, F Haapalinna, N Nykänen, ... Journal of Alzheimer's Disease 75 (3), 751-765, 2020 | 12 | 2020 |
| Subtle cognitive impairment and Alzheimer’s disease-type pathological changes in cerebrospinal fluid are common among neurologically healthy subjects F Haapalinna, M Kokki, O Jääskeläinen, M Hallikainen, S Helisalmi, ... Journal of Alzheimer's Disease 62 (1), 165-174, 2018 | 12 | 2018 |
| Comprehensive strategy for proton chemical shift prediction: Linear prediction with nonlinear corrections R Laatikainen, T Hassinen, J Lehtivarjo, M Tiainen, J Jungman, ... Journal of Chemical Information and Modeling 54 (2), 419-430, 2014 | 11 | 2014 |
| Vitamin D supplementation and serum neurofilament light chain in interferon‐beta‐1b‐treated MS patients K Hänninen, O Jääskeläinen, SK Herukka, M Soilu‐Hänninen Brain and Behavior 10 (9), e01772, 2020 | 10 | 2020 |
| Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion K Katisko, E Solje, P Korhonen, O Jääskeläinen, S Loppi, P Hartikainen, ... Journal of Neurology 267, 76-86, 2020 | 10 | 2020 |
| Serum neurofilament light in patients with frontotemporal dementia caused by CHMP2B mutation A Toft, P Roos, O Jääskeläinen, CS Musaeus, EE Henriksen, ... Dementia and Geriatric Cognitive Disorders 49 (6), 533-538, 2021 | 9 | 2021 |
| A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions AL Kaipainen, J Pitkänen, F Haapalinna, O Jääskeläinen, H Jokinen, ... Neuroradiology 63, 2035-2046, 2021 | 8 | 2021 |
| Plasma Neurofilament Light Chain (NF-L) is a prognostic biomarker for cortical damage evolution but not for cognitive impairment or Epileptogenesis following experimental TBI M Heiskanen, O Jääskeläinen, E Manninen, S Das Gupta, P Andrade, ... International Journal of Molecular Sciences 23 (23), 15208, 2022 | 6 | 2022 |
| The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis L Juutinen, K Ahinko, S Hagman, P Basnyat, O Jääskeläinen, SK Herukka, ... Multiple Sclerosis and Related Disorders, 105517, 2024 | | 2024 |
| Metabolic profiling of neurodegenerative diseases: With emphasis on Alzheimer's disease and C9ORF72-gene hexanucleotide repeat expansion associated frontotemporal lobar … O Jääskeläinen Itä-Suomen yliopisto, 2022 | | 2022 |
